Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 69 Records) |
Query Trace: Anemia and BRCA1[original query] |
---|
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO). Clinical cancer research : an official journal of the American Association for Cancer Research 2018 12 25 (9): 2717-2724. Turner Nicholas C, Telli Melinda L, Rugo Hope S, Mailliez Audrey, Ettl Johannes, Grischke Eva-Maria, Mina Lida A, Balmaña Judith, Fasching Peter A, Hurvitz Sara A, Wardley Andrew M, Chappey Colombe, Hannah Alison L, Robson Mark E, |
Two truncating variants in FANCC and breast cancer risk. Scientific reports 2019 Aug 9 (1): 12524. Dörk Thilo, Peterlongo Paolo, Mannermaa Arto, Bolla Manjeet K, Wang Qin, Dennis Joe, Ahearn Thomas, Andrulis Irene L, Anton-Culver Hoda, Arndt Volker, Aronson Kristan J, Augustinsson Annelie, Freeman Laura E Beane, Beckmann Matthias W, Beeghly-Fadiel Alicia, Behrens Sabine, Bermisheva Marina, Blomqvist Carl, Bogdanova Natalia V, Bojesen Stig E, Brauch Hiltrud, Brenner Hermann, Burwinkel Barbara, Canzian Federico, Chan Tsun L, Chang-Claude Jenny, Chanock Stephen J, Choi Ji-Yeob, Christiansen Hans, Clarke Christine L, Couch Fergus J, Czene Kamila, Daly Mary B, Dos-Santos-Silva Isabel, Dwek Miriam, Eccles Diana M, Ekici Arif B, Eriksson Mikael, Evans D Gareth, Fasching Peter A, Figueroa Jonine, Flyger Henrik, Fritschi Lin, Gabrielson Marike, Gago-Dominguez Manuela, Gao Chi, Gapstur Susan M, García-Closas Montserrat, García-Sáenz José A, Gaudet Mia M, Giles Graham G, Goldberg Mark S, Goldgar David E, Guénel Pascal, Haeberle Lothar, Haiman Christopher A, Håkansson Niclas, Hall Per, Hamann Ute, Hartman Mikael, Hauke Jan, Hein Alexander, Hillemanns Peter, Hogervorst Frans B L, Hooning Maartje J, Hopper John L, Howell Tony, Huo Dezheng, Ito Hidemi, Iwasaki Motoki, Jakubowska Anna, Janni Wolfgang, John Esther M, Jung Audrey, Kaaks Rudolf, Kang Daehee, Kapoor Pooja Middha, Khusnutdinova Elza, Kim Sung-Won, Kitahara Cari M, Koutros Stella, Kraft Peter, Kristensen Vessela N, Kwong Ava, Lambrechts Diether, Marchand Loic Le, Li Jingmei, Lindström Sara, Linet Martha, Lo Wing-Yee, Long Jirong, Lophatananon Artitaya, Lubi?ski Jan, Manoochehri Mehdi, Manoukian Siranoush, Margolin Sara, Martinez Elena, Matsuo Keitaro, Mavroudis Dimitris, Meindl Alfons, Menon Usha, Milne Roger L, Mohd Taib Nur Aishah, Muir Kenneth, Mulligan Anna Marie, Neuhausen Susan L, Nevanlinna Heli, Neven Patrick, Newman William G, Offit Kenneth, Olopade Olufunmilayo I, Olshan Andrew F, Olson Janet E, Olsson Håkan, Park Sue K, Park-Simon Tjoung-Won, Peto Julian, Plaseska-Karanfilska Dijana, Pohl-Rescigno Esther, Presneau Nadege, Rack Brigitte, Radice Paolo, Rashid Muhammad U, Rennert Gad, Rennert Hedy S, Romero Atocha, Ruebner Matthias, Saloustros Emmanouil, Schmidt Marjanka K, Schmutzler Rita K, Schneider Michael O, Schoemaker Minouk J, Scott Christopher, Shen Chen-Yang, Shu Xiao-Ou, Simard Jacques, Slager Susan, Smichkoska Snezhana, Southey Melissa C, Spinelli John J, Stone Jennifer, Surowy Harald, Swerdlow Anthony J, Tamimi Rulla M, Tapper William J, Teo Soo H, Terry Mary Beth, Toland Amanda E, Tollenaar Rob A E M, Torres Diana, Torres-Mejía Gabriela, Troester Melissa A, Truong Thérèse, Tsugane Shoichiro, Untch Michael, Vachon Celine M, Ouweland Ans M W van den, Veen Elke M van, Vijai Joseph, Wendt Camilla, Wolk Alicja, Yu Jyh-Cherng, Zheng Wei, Ziogas Argyrios, Ziv Elad, , , Dunning Alison M, Pharoah Paul D P, Schindler Detlev, Devilee Peter, Easton Douglas |
Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility. Molecular genetics & genomic medicine 2019 7 7 (9): e863. Keupp Katharina, Hampp Stephanie, Hübbel Annette, Maringa Monika, Kostezka Sarah, Rhiem Kerstin, Waha Anke, Wappenschmidt Barbara, Pujol Roser, Surrallés Jordi, Schmutzler Rita K, Wiesmüller Lisa, Hahnen Er |
Is BRCA mutational status a predictor of platinum-based chemotherapy related hematologic toxicity in high-grade serous ovarian cancer patients? Gynecologic oncology 2019 May . Tomao Federica, Musacchio Lucia, Di Mauro Federica, Boccia Serena Maria, Di Donato Violante, Giancotti Antonella, Perniola Giorgia, Palaia Innocenza, Muzii Ludovico, Benedetti Panici Pierlui |
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2019 1 30 (4): 558-566. Robson M E, Tung N, Conte P, Im S-A, Senkus E, Xu B, Masuda N, Delaloge S, Li W, Armstrong A, Wu W, Goessl C, Runswick S, Domchek S |
Correction to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. Breast cancer research and treatment 2020 7 183 (2): 491. Alter Blanche P, Best Ana |
Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations. The breast journal 2020 6 26 (8): 1572-1582. Bayraktar Soley, Zhou Jade Z, Bassett Roland, Gutierrez Barrera Angelica M, Layman Rachel M, Valero Vicente, Arun Ba |
Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis. Breast cancer research and treatment 2020 Jun . Alter Blanche P, Best Ana |
Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2020 5 32 (2): 149-162. Wang Nan, Li Kun, Huang Wenfa, Kong Weiyao, Liu Xiaoran, Shi Weijie, Xie Feng, Jiang Hanfang, Song Guohong, Di Lijun, Wang Quanren, Yu Jianjun, Li Huipi |
Exploring the Role of Mutations in Fanconi Anemia Genes in Hereditary Cancer Patients. Cancers 2020 4 12 (4): . Del Valle Jesús, Rofes Paula, Moreno-Cabrera José Marcos, López-Dóriga Adriana, Belhadj Sami, Vargas-Parra Gardenia, Teulé Àlex, Cuesta Raquel, Muñoz Xavier, Campos Olga, Salinas Mónica, de Cid Rafael, Brunet Joan, González Sara, Capellá Gabriel, Pineda Marta, Feliubadaló Lídia, Lázaro Con |
Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy. JNCI cancer spectrum 2020 4 4 (1): pkz085. Rugo Hope S, Ettl Johannes, Hurvitz Sara A, Gonçalves Anthony, Lee Kyung-Hun, Fehrenbacher Louis, Mina Lida A, Diab Sami, Woodward Natasha E, Yerushalmi Rinat, Goodwin Annabel, Blum Joanne L, Martin Miguel, Quek Ruben G W, Tudor Iulia Cristina, Bhattacharyya Helen, Gauthier Eric, Litton Jennifer K, Eiermann Wolfga |
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL). Lung cancer (Amsterdam, Netherlands) 2020 10 150 62-69. Garcia-Campelo Rosario, Arrieta Oscar, Massuti Bartomeu, Rodriguez-Abreu Delvys, Granados Ana Laura Ortega, Majem Margarita, Vicente David, Lianes Pilar, Bosch-Barrera Joaquim, Insa Amelia, Dómine Manuel, Reguart Noemí, Guirado María, Sala María Ángeles, Vázquez-Estevez Sergio, Caro Reyes Bernabé, Drozdowskyj Ana, Verdú Ana, Karachaliou Niki, Molina-Vila Miguel Angel, Rosell Rafael, |
Phase Ib Dose Expansion and Translational Analyses of Olaparib in Combination with Capivasertib in Recurrent Endometrial, Triple-Negative Breast, and Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 Sep . Westin Shannon N, Labrie Marilyne, Litton Jennifer K, Blucher Aurora, Fang Yong, Vellano Christopher P, Marszalek Joseph R, Feng Ningping, Ma XiaoYan, Creason Allison, Fellman Bryan, Yuan Ying, Lee Sanghoon, Kim Tae-Beom, Liu Jinsong, Chelariu-Raicu Anca, Chen Tsun Hsuan, Kabil Nashwa, Soliman Pamela T, Frumovitz Michael, Schmeler Katheleen M, Jazaeri Amir, Lu Karen H, Murthy Rashmi, Meyer Larissa A, Sun Charlotte C, Sood Anil K, Coleman Robert L, Mills Gordon |
An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline BRCA1/2 Mutation and Platinum-sensitive Recurrent Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 2 27 (9): 2452-2458. Li Ning, Bu Hualei, Liu Jihong, Zhu Jianqing, Zhou Qi, Wang Li, Yin Rutie, Wu Xiaohua, Yao Shuzhong, Gu Kangsheng, Zhang Hui, Li Guiling, Pan Hongming, Wu Qiang, An Ruifang, Yang Xinfeng, Zhu Yaping, Wan Xiaoping, Duan Wei, Xiong Jianping, Guo Hongyan, Lou Ge, Wang Jing, Hu Wenjing, Zhang Xin, Meng Yuanguang, Zhang Ben, Wang Yuting, Wang Quanren, Wu Lingyi |
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors. Scientific reports 2021 2 11 (1): 4433. Poveda Andres, Oaknin Ana, Romero Ignacio, Guerrero-Zotano Angel, Fariñas-Madrid Lorena, Rodriguez-Freixinos Victor, Mallol Pedro, Lopez-Reig Raquel, Lopez-Guerrero Jose Anton |
Spectrum of Germline Mutations Within Fanconi Anemia-Associated Genes Across Populations of Varying Ancestry. JNCI cancer spectrum 2022 8 5 (1): . Chan Sock Hoai, Ni Ying, Li Shao-Tzu, Teo Jing Xian, Ishak Nur Diana Binte, Lim Weng Khong, Ngeow Joan |
Serous Tubal Intraepithelial Carcinoma in a Risk-reducing Salpingo-oophorectomy Specimen From a RAD51D Mutation Carrier: A Case Report. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2022 2 42 (1): 89-92. Gregory-Davis Kalin J, Walker Allison, Colello Laura S, McKinnon Wendy, Everett Elise, Chang Martin |
Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2-mutation carriers. Cancer medicine 2022 11 . Mori Tomoharu, Okamoto Yusuke, Mu Anfeng, Ide Yoshimi, Yoshimura Akiyo, Senda Noriko, Inagaki-Kawata Yukiko, Kawashima Masahiro, Kitao Hiroyuki, Tokunaga Eriko, Miyoshi Yasuo, Ohsumi Shozo, Tsugawa Koichiro, Ohta Tomohiko, Katagiri Toyomasa, Ohtsuru Shigeru, Koike Kaoru, Ogawa Seishi, Toi Masakazu, Iwata Hiroji, Nakamura Seigo, Matsuo Keitaro, Takata Mino |
Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study. Frontiers in oncology 2022 10 12 898150. Tashiro Ryota, Kawazoe Hitoshi, Mamishin Kanako, Seto Keisuke, Udagawa Ryoko, Saito Yoshimasa, Hashimoto Hironobu, Shimoi Tatsunori, Yonemori Kan, Yonemura Masahito, Terakado Hiroyuki, Kawasaki Toshikatsu, Furukawa Tetsuya, Nakamura Tomono |
DNA-repair status should be assessed in treatment-emergent neuroendocrine prostate cancer before platinum-based therapy. The Prostate 2022 1 82 (4): 464-474. Zhu Shimiao, Zhang Zheng, Zhang Hui, Liu Zihao, Liu Min, Liu Qing, Zang Li, Wang Lili, Ji Junpeng, Wu Bo, Sun Libin, Zhang Zhenting, Cao Heran, Wang Yong, Wang Haitao, Shang Zhiqun, Niu Yuanj |
Prevalence of FANCM germline variants in BRCA1/2 negative breast and/or ovarian cancer patients from Pakistan. Familial cancer 2022 Jul . Rashid Muhammad Usman, Muhammad Noor, Shehzad Umara, Khan Faiz Ali, Loya Asif, Hamann U |
A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer. Journal of cancer research and clinical oncology 2023 8 . Qiao-Yan Zhu, Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Rong Wang, Xiao-Lin Li, Wei-Wu Ye, Xiao-Wen Ding, Xiao-Jia Wang, Wen-Ming C |
PARP Inhibitor Combinations in First Line mCRPC: A Systematic Review and Meta-Analysis. BJU international 2023 7 . Rashid K Sayyid, Zachary Klaassen, Alejandro Berlin, Soumyajit Roy, Leonardo R Brandão, Rui Bernardino, Julian Chavarriaga, Di Maria Jiang, Daniel E Spratt, Neil E Fleshner, Christopher J D Wall |
Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
The pathogenic role of the BRCA2 c.7847C>T (p.Ser2616Phe) variant in breast and ovarian cancer predisposition. Cancer science 2023 4 . Yamazawa Kazuki, Sugano Kokichi, Tanakaya Kohji, Inoue Satomi, Murakami Haruka, Nakashima Moeko, Adachi Masataka, Oki Shinya, Makabe Takeshi, Yamashita Hiroshi, Ueki Arisa, Sasaoka Ayako, Nakashoji Ayako, Kinoshita Takayuki, Matsunaga Tatsuo, Arai Masami, Nakamura Seigo, Miyata Hiroaki, Ikegami Masachika, Mano Hiroyuki, Kohsaka Shinji, Matsui Aki |
Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1/2 Mutation: Results From the TAPUR Study. JCO precision oncology 2023 2 7 e2200505. Yang Eddy S, Halabi Susan, Rothe Michael, Garrett-Mayer Elizabeth, Mangat Pam K, Pisick Evan, Dib Elie, Burgess Earle F, Zakem Michael, Rohatgi Nitin, Bilen Mehmet A, O'Lone Raegan, Grantham Gina N, Schilsky Richard |
Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population. International journal of molecular sciences 2023 2 24 (4): . Morales-Pison Sebastian, Morales-González Sarai, Fernandez-Ramires Ricardo, Tapia Julio C, Maldonado Edio, Calaf Gloria M, Jara Lili |
[BRCA2 Mutation Profile in a Proband with Hereditary Breast and Ovarian Cancer-Two Germline Pathogenic Variants Aligned in the Cis Position]. Gan to kagaku ryoho. Cancer & chemotherapy 2023 11 50 (10): 1089-1091. Seigo Yukisawa, Toshiyuki Kakinuma, Junko Yotsumoto, Kentaro Kawakami, Junji Furukawa, Hiroharu Shinoza |
The use of Ctrough for the therapeutic drug monitoring of olaparib in patients with ovarian cancer. European review for medical and pharmacological sciences 2023 1 26 (24): 9426-9436. Stanis?awiak-Rudowicz J, Sza?ek E, Grzebalska M, Urjasz H, Michalak M, M?dry R, Grze?kowiak |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: